Also:

Northridge-based MiniMed Inc. said it expects U.S. sales of insulin pumps to increase 35% this quarter and the introduction of a new pump system to spur a “significant uptick” in growth this year. Its shares rose $3.50 to close at $36.50 on Nasdaq.